Sophia Genetics Sa (SOPH)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Sophia Genetics Sa Stock (SOPH) Company Profile

Sophia Genetics Sa

Healthcare (1118)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SOPH's Discussions on Twitter

Compare SOPH vs VEEV, TEM, BTSG, HQY, WAY

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SOPH Sophia Genetics Sa	4.64	329.68M	77.27M	-79.00M	-48.46M	-1.1694
VEEV Veeva Systems Inc	178.17	29.72B	3.20B	908.91M	1.42B	5.4155
TEM Tempus Ai Inc	50.13	8.85B	1.27B	-245.03M	-245.36M	-1.4071
BTSG Brightspring Health Services Inc	37.98	7.42B	11.99B	24.18M	234.31M	0.2956
HQY Healthequity Inc	77.29	6.56B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	24.21	4.72B	1.10B	112.09M	283.19M	0.6096

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-18	Eingeleitet	Craig Hallum	Buy
2024-08-07	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-06-27	Eingeleitet	Guggenheim	Buy
2023-11-29	Eingeleitet	RBC Capital Mkts	Outperform
2023-07-05	Fortgesetzt	JP Morgan	Overweight
2023-01-03	Eingeleitet	BTIG Research	Buy
2022-11-23	Eingeleitet	Credit Suisse	Neutral
2021-10-15	Fortgesetzt	Cowen	Outperform
2021-08-17	Eingeleitet	Cowen	Outperform
2021-08-17	Eingeleitet	Credit Suisse	Outperform
2021-08-17	Eingeleitet	JP Morgan	Overweight
2021-08-17	Eingeleitet	Morgan Stanley	Overweight

Alle ansehen

Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten

Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)

Sophia Genetics Sa (SOPH)

Sophia Genetics Sa Stock (SOPH) Company Profile

Compare SOPH vs VEEV, TEM, BTSG, HQY, WAY

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten

Sophia Genetics Earnings Call: Growth Surges, Losses Linger - TipRanks

Aug PreEarnings: Can SOPHiA GENETICS SA stock double in the next yearJuly 2025 Momentum & High Yield Equity Trading Tips - baoquankhu1.vn

SOPHiA GENETICS (SOPH) Q4 Loss Deepens And Reinforces Bearish Profitability Concerns - Sahm

Will SOPHiA GENETICS SA stock go up in YEARQuarterly Trade Report & Technical Entry and Exit Alerts - baoquankhu1.vn

SOPHiA GENETICS Q4 Earnings Call Highlights - Defense World

Sophia Genetics SA (SOPH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q4 2025 Earnings Call Transcript - Insider Monkey

BTIG Maintains Buy on SOPHiA GENETICS S.A. (SOPH) March 03, 2026 - Meyka

SOPHiA GENETICS (NASDAQ: SOPH) registers 75,000 warrant shares for resale - Stock Titan

BTIG reiterates Sophia Genetics stock rating on customer growth - Investing.com

Fulgent Genetics (FLGT) Earnings Transcript - AOL.com

SOPHiA GENETICS S.A. Q4 2025 Earnings Call Summary - Yahoo Finance

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026 - Finviz

SOPHiA GENETICS (SOPH) Q4 2025 Earnings Transcript - The Globe and Mail

SOPHiA GENETICS SA reports results for the quarter ended December 31Earnings Summary - TradingView

SOPHiA GENETICS SA 2025 Q4ResultsEarnings Call Presentation (NASDAQ:SOPH) 2026-03-03 - Seeking Alpha

SOPHiA GENETICS (NASDAQ:SOPH) Posts Quarterly Earnings Results, Misses Estimates By $0.08 EPS - MarketBeat

Sophia Genetics reports fourth quarter and full year 2025 results - marketscreener.com

SOPHiA GENETICS (SOPH) 2025 20-F flags losses, platform and regulatory risks - Stock Titan

[6-K] SOPHiA GENETICS SA Current Report (Foreign Issuer) | SOPH SEC FilingForm 6-K - Stock Titan

Sophia Genetics Q4 Earnings Summary & Key TakeawaysSophia Genetics (NASDAQ:SOPH) - Benzinga

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results - PR Newswire

A Look at Sophia Genetics's Upcoming Earnings ReportSophia Genetics (NASDAQ:SOPH) - Benzinga

SOPHiA GENETICS (SOPH) to Release Earnings on Tuesday - Defense World

SOPH Should I Buy - Intellectia AI

SOPHiA GENETICS SA expected to post a loss of 24 cents a shareEarnings Preview - TradingView

Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Expands By 194.3% - MarketBeat

Why The SOPHiA GENETICS (SOPH) Narrative Is Shifting On Richer Valuation And Growth Expectations - Yahoo Finance UK

SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference - Finviz

SOPHiA GENETICS CEO, president in TD Cowen fireside chat March 4 - Stock Titan

SOPHiA GENETICS (SOPH) Projected to Announce Earnings on Tuesday - MarketBeat

SOPH (NASDAQ: SOPH) insider sale notice lists 380 RSUs and recent 10b5-1 trades - Stock Titan

Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million - AOL.com

Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough - AOL.com

Swiss–Japanese Partnership Advances Precision Oncology through Liquid Biopsy and Companion Diagnostics - Switzerland Global Enterprise

Can SOPHiA GENETICS SA continue delivering strong returns2025 Technical Patterns & Daily Growth Stock Investment Tips - mfd.ru

Aug Patterns: Will SOPHiA GENETICS SA stock go up in YEARQuarterly Performance Summary & Reliable Price Breakout Alerts - baoquankhu1.vn

SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat

Moderna Just Crushed Estimates While Everyone Was Looking the Other Way - AOL.com

Can SOPHiA GENETICS SA (90B) stock deliver double digit returnsJobs Report & Free Safe Capital Growth Stock Tips - mfd.ru

Is SOPHiA GENETICS SA a potential multi baggerJuly 2025 Outlook & Free Fast Gain Swing Trade Alerts - mfd.ru

Why The Story Behind SOPHiA GENETICS (SOPH) Is Shifting After The Latest Target Reset - Yahoo Finance

Day Trade: Can SOPHiA GENETICS SA sustain its profitabilityJuly 2025 Action & Long-Term Investment Growth Plans - baoquankhu1.vn

SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems - Finviz

SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems – Company AnnouncementFT.com - Financial Times

SOPHiA GENETICS Appoints Ken Freedman as Chief Revenue Officer - Quantisnow

Aug Wrap: Can SOPHiA GENETICS SA sustain its profitability2025 Dividend Review & Technical Entry and Exit Tips - baoquankhu1.vn

Painful week for individual investors invested in SOPHiA GENETICS SA (NASDAQ:SOPH) after 11% drop, institutions also suffered losses - simplywall.st

VIX Spike: Is SOPHiA GENETICS SA benefiting from interest rate changesJuly 2025 Sector Moves & Precise Trade Entry Recommendations - baoquankhu1.vn

Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 68.3% - MarketBeat

Should You Buy Guardant Health Before Feb. 19? - AOL.com

Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SOPH